Navigation Links
HepaLife Announces Scientific Presentation of PBS-1 Cell Line at,International Influenza Meeting

ownership of its business, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and research scientists, changes in interest rates, inflationary factors, and other specific risks. We currently have no commercial products intended to diagnose, treat, prevent or cure any disease. The statements contained in this press release regarding our on going research and development and the results attained by us to date have not been evaluated by the Food and Drug Administration. There can be no assurance that further research and development, and/or whether clinical trial results, if any, will validate and support the results of our preliminary research and studies. Further, there can be no assurance that the necessary regulatory approvals will be obtained or that HepaLife will be able to develop commercially viable products on the basis of its technologies. In addition, other factors that could cause actual results to differ materially are discussed in the Company's most recent Form 10-Q and Form 10-K filings with the Securities and Exchange Commission. These reports and filings may be inspected and copied at the Public Reference Room maintained by the U.S. Securities & Exchange Commission at 100 F Street, N.E., Washington, D.C. 20549. You can obtain information about operation of the Public Reference Room by calling the U.S. Securities & Exchange Commission at 1-800-SEC-0330. The U.S. Securities & Exchange Commission also maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the U.S. Securities & Exchange Commission at http://www.sec.gov. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:11/24/2014)... 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) ... and CEO of Inovio Pharmaceuticals, will be joined by members ... Nasdaq Opening Bell tomorrow, Tuesday November 25, 2014, at 9:30 ... listing on the Nasdaq Global Select Market.  ... are honored to ring the Nasdaq Opening Bell on behalf ...
(Date:11/22/2014)...  New data demonstrates that flibanserin, a novel, non-hormonal ... female sexual dysfunction, Hypoactive Sexual Desire Disorder (HSDD), does ... premenopausal women when taken at bedtime. The data was ... North America,s (SMSNA) 20th Annual Fall Scientific ... SMSNA accepted this study as a late breaking ...
(Date:11/22/2014)... Statistics released from a number of organizations show that ... holidays, beginning with Thanksgiving eve, which is now termed ... data, highlighted in an Infographic released by ... annual Sober Days for the Holidays public awareness ... increased rates of DUI injuries and deaths during the ...
Breaking Medicine Technology:Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 2Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 3Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 2Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 3Alarming Stats Show Holiday Drinking an Issue for Many 2
... Wis., Oct. 26 Shopko is pleased to announce the ... President/GMM of Apparel and Accessories. He will have primary responsibility ... business and marketing plans. , Csuy joined Shopko in ... 2008. He added Men,s apparel to his responsibilities in December ...
... Thousands of Clinical Cardiovascular Practices to Promote Practice ... 26 The American College of Cardiology today ... first-ever registry-based cardiovascular network to link thousands of ... ACC,s National Cardiovascular Data Registry(R) (NCDR), the preeminent ...
Cached Medicine Technology:Csuy Named Senior Vice President/General Merchandise Manager 2American College of Cardiology Launches the Nation's First Registry-Based Cardiovascular Practice Network 2American College of Cardiology Launches the Nation's First Registry-Based Cardiovascular Practice Network 3
(Date:11/24/2014)... CA (PRWEB) November 24, 2014 The ... its readers reviews of affordable skin care products, recently ... casual blog offers readers a wide variety of articles, ... as well as organic skincare alternatives. , According to ... Care Journal’s main content includes thoroughly researched reviews, tips ...
(Date:11/24/2014)... Abington Health is pleased to ... The Neurology Group and has been named associate medical ... A graduate of Vinnica Medical University in Ukraine, Ternopolska ... Center in Philadelphia and completed a fellowship in Multiple ... Weill Cornell Medical College. Ternopolska is board certified in ...
(Date:11/24/2014)... 2014 Recently, SweetDressy.com, a well-known dress ... new collection of 2014 Evening Dresses. All these fresh ... the company’s marketing manager, the special offer is valid ... more. , Sweetdressy.com has been working well in the ... the latest designs. Their new dresses may be the ...
(Date:11/24/2014)... TX (PRWEB) November 24, 2014 The ... all of the wrong ingredients. Consistently consuming a diet ... to develop stores of excess fat that typically accumulate ... problems and rearing its ugly head in the form ... , When dieters make the decision to rid themselves ...
(Date:11/24/2014)... 2014 Dr. Michael Kettel , a ... appeared on NBC to discuss egg freezing as a viable ... trending in the news recently, with new company benefits at ... , “[The companies] see it as a way ... career hot path.” Says Dr. Kettel. , Up until a ...
Breaking Medicine News(10 mins):Health News:Skin Care Advice Blog The Healthy Skin Care Journal Now Accessible to the Public 2Health News:Nataliya Ternopolska Named Associate Medical Director of Abington Health’s Multiple Sclerosis Center 2Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 2Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 3Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 4Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 3
... of the digestive disorder have slightly higher death rate, study ... milder symptoms of celiac disease face a slightly higher risk ... Cancer and heart disease were the main causes of death ... people who had had small-intestinal biopsies in childhood, the researchers ...
... expects first batches to be available within a month , ... Drug Administration on Tuesday approved four new H1N1 swine flu ... four weeks. , "Today,s approval is good news for our ... Dr. Margaret A. Hamburg said in a news release. "This ...
... , WASHINGTON, Sept. 15 The American ... impact on health care issues conducted by Pulse Opinion Research, LLC, ... of Americans believe that high immigration levels have had an adverse ... Republicans (89%) felt more strongly on the issue, but Democrats ...
... Cowen Group, Inc. (Nasdaq: COWN ) announced today that ... the Investment Banking Group to lead the Firm,s medical technology practice. ... to Peter Reikes, Head of Cowen,s Health Care Investment Banking group. ... of health care investment banking experience and joins Cowen most recently ...
... ... Business , ... (Vocus) September 15, 2009 -- Health Advocate, the nation’s leading independent healthcare advocacy and assistance ... to meet the needs of its growing business. With the addition of a new ...
... SARASOTA Fla., Sept. 15 A most unusual home health care firm ... think they can do. , , When an ... members often are thrust into their first experience with home health care. ... the caregivers simply react to problems, and expectations are low. Her people ...
Cached Medicine News:Health News:FDA Approves 4 Swine Flu Vaccines 2Health News:FDA Approves 4 Swine Flu Vaccines 3Health News:FDA Approves 4 Swine Flu Vaccines 4Health News:National Poll Finds Most Americans Believe Immigration Adversely Affects the Quality and Cost of Healthcare 2Health News:Cowen Announces Hiring of Don Munoz to Lead Medical Technology Practice; 5th Senior-Level Addition to Cowen's Health Care Franchise in 2009 2Health News:Health Advocate, Inc. Expands Headquarters 2Health News:Health Advocate, Inc. Expands Headquarters 3Health News:Seniors May Think They Can't, But They Can 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: